Drug and Medication Industry in North America Countries: Market Research Reports, Statistics and Analysis

Company Report: Drug And Medication In The United States For Year ...

... In antiretroviral drugs being led by companies such as gilead. In 2011, hiv drugs accounted for $6.4 Billion gilead S sales and they continue to improve treatment in this area. They also appear to be leading ...

Quality By Design - Company Report For Year 2013

Company Report: Drug And Medication In Germany And North America ...

Drug And Medication Sector In The United States

... Of emerging contaminants in water supplies antidepressants, endocrine disruptors Impacts on aquatic life Strengthening of the regulatory framework Baseline of data for drinking water supplies Assess ...

U.s. Drug And Medication Business Analysis

U.s. Drug And Medication Industry : Innovation And Technology Tre ...

Vaccine Market Analysis In The United States

... B ........................................................................................................ hepatitis b (vaccine) hib ................................................................................... Haemophilus influenzae b (vaccine) hic ...

U.s. Drug And Medication Business : Innovation And Technology Tre ...

... Years is not necessarily less than the increase in life expectancy. Since the lifetime risk of being diagnosed with cancer is about 40%, the 1978-2004 increase in the lagged stock of cancer drugs increased the life ...

Drug Industry Analysis In The United States And Canada

... To production interruptions and diminished capacity Economic choices are made where older, less profitable drugs are eliminated as new generics come to market By year-end 2012, we will see $34b in new ...